Načítá se...
MicroRNAs in treatment-induced neuroendocrine differentiation in prostate cancer
Prostate cancer is a condition commonly associated with men worldwide. Androgen deprivation therapy remains one of the targeted therapies. However, after some years, there is biochemical recurrence and metastatic progression into castration-resistant prostate cancer (CRPC). CRPC cases are treated wi...
Uloženo v:
| Vydáno v: | Cancer Drug Resist |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
OAE Publishing Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7793563/ https://ncbi.nlm.nih.gov/pubmed/33426506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/cdr.2020.30 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|